| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 05/23/2007 | EP1788000A1 Agent for preventing and ameliorating obesity |
| 05/23/2007 | EP1787647A1 Remedy for glomerular diseae |
| 05/23/2007 | EP1786814A1 Bicyclononene derivatives as renin inhibitors |
| 05/23/2007 | EP1786800A2 Substituted biaryl piperazinyl-pyridine analogues |
| 05/23/2007 | EP1786457A1 Use of il-6 in vascular complications |
| 05/23/2007 | EP1786435A1 Combination therapies employing vitamin b6 related compounds and ace inhibitors and uses thereof for the treatment of diabetic disorders |
| 05/23/2007 | EP1786426A1 Soluble amide & ester pyrazinoylguanidine sodium channel blockers |
| 05/23/2007 | EP1786410A2 The treatment of inflammatory disorders and pain |
| 05/23/2007 | EP1786407A1 Use of vitamin ds to treat kidney disease |
| 05/23/2007 | EP1442040B1 Bridged bicycle (1,4) benzodiazepine vasopressin receptor antagonists |
| 05/23/2007 | EP1416929A4 Cancer treatment with gö6976 and its related compounds |
| 05/23/2007 | EP1369419B1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
| 05/23/2007 | EP1363885B1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 05/23/2007 | EP1196427B1 C-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 05/23/2007 | EP0873407B1 Apo-2 ligand |
| 05/23/2007 | CN1966047A Chinese medicinal formulation for treating prostate hyperplasia |
| 05/23/2007 | CN1966020A Chinese medicinal pill with date for treating liver and kidney diseases |
| 05/23/2007 | CN1966009A Medicament for treating avian nephropathogenic infectious bronchitis |
| 05/23/2007 | CN1965997A Chinese medicinal wine |
| 05/23/2007 | CN1965962A Medicament for treating chronic nephritis and method for preparing same |
| 05/23/2007 | CN1965953A Compound medicinal granule capable of tonifying kidney and replenishing qi and method for preparing same |
| 05/23/2007 | CN1965911A Chinese proprietary medicine for treating urinary calculus |
| 05/23/2007 | CN1965858A Medicament for preventing and treating renal calculus through regulating concentration of citric acid in urine |
| 05/23/2007 | CN1965839A Sustained release microsphere of finasteride and its analogue, preparation process and use thereof |
| 05/23/2007 | CN1317001C Compound essential oil for treating prostatitis |
| 05/23/2007 | CN1316971C Pharmaceutical composition with sustained release function and its preparing process |
| 05/22/2007 | US7220867 Dissolving with crystal growth inihibitos; drying |
| 05/22/2007 | US7220834 FHIT proteins and nucleic acids and methods based thereon |
| 05/22/2007 | US7220771 Jun n-terminal kinase inhibitors |
| 05/22/2007 | US7220765 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
| 05/22/2007 | US7220754 Mono-ester and asymmetrically substatuted di-ester pro-drugs of dopamide D1 receptor agonists |
| 05/22/2007 | US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example |
| 05/22/2007 | US7220748 Administering, to a patient in need of such treatment, an effective amount of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine or a salt thereof |
| 05/22/2007 | US7220722 Lipoprotein-regulating medicants |
| 05/22/2007 | CA2286870C Indazole amide compounds as serotoninergic agents |
| 05/22/2007 | CA2241466C Pharmaceutical composition containing angiotensin ii antagonist |
| 05/18/2007 | WO2007055418A1 Aza-substituted spiro derivative |
| 05/18/2007 | WO2007054782A1 Stabilized lanthanum carbonate compositions |
| 05/18/2007 | WO2007054778A1 Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as pde5 inhibitors |
| 05/18/2007 | WO2007054269A2 Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts |
| 05/18/2007 | WO2007015157A3 Mc4r-ag0nists for the treatment of urinary tract dysfunction |
| 05/18/2007 | WO2007003411A3 Kinin antagonists for treating bladder dysfunction |
| 05/18/2007 | WO2006025057A8 Use of il-6 in vascular complications |
| 05/18/2007 | CA2629018A1 Aza-substituted spiro derivative |
| 05/18/2007 | CA2626894A1 Stabilized lanthanum carbonate compositions |
| 05/18/2007 | CA2624703A1 Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts |
| 05/17/2007 | US20070112046 2'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase Inhibitors |
| 05/17/2007 | US20070111945 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 05/17/2007 | US20070111942 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/17/2007 | US20070110800 Pharmaceutical composition having uniform drug distribution and potency |
| 05/17/2007 | US20070110745 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/16/2007 | EP1785142A1 Treatment of chronic kidney disease (CKD) subjects using lanthanum compounds |
| 05/16/2007 | EP1785141A1 Stabilized lanthanum carbonate compositions |
| 05/16/2007 | EP1785140A1 Composition and kit for the treatment of urinary disorders |
| 05/16/2007 | EP1785134A2 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 05/16/2007 | EP1784186A2 Methods for treating or preventing erectile dysfunction or urinary incontinence |
| 05/16/2007 | EP1784178A1 Aryl (or heteroaryl) azolylcarbinols |
| 05/16/2007 | EP1615634B1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 05/16/2007 | EP1465638B1 Phosphate transport inhibitors |
| 05/16/2007 | EP1448544B1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/16/2007 | EP1265900B1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d|pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 05/16/2007 | CN1964979A Novel water-soluble prodrug |
| 05/16/2007 | CN1964950A Propane-1,3-dione derivative or its salt |
| 05/16/2007 | CN1964729A Composition for prevention and treatment of urinary incontinence |
| 05/16/2007 | CN1962641A Metalloproteinase inhibitors |
| 05/16/2007 | CN1962596A Ketone compounds and compositions for cholesterol management and related uses |
| 05/16/2007 | CN1961955A Chinese medicinal formulation for treating hyperplasia of prostate |
| 05/16/2007 | CN1961870A Method for preparing sustained releasing microcapsule of phenoxybenzamine hydrochloride and ethyl cellulose |
| 05/16/2007 | CN1315847C 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/16/2007 | CN1315840C Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives used as drug for treating pain |
| 05/16/2007 | CN1315836C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/16/2007 | CN1315835C Polycyclic guanine phosphodiesterase v inhibitors |
| 05/16/2007 | CN1315833C Azaindole kinase inhibitors |
| 05/16/2007 | CN1315822C Quinoline derivatives having VEGF inhibiting activity |
| 05/16/2007 | CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 05/15/2007 | US7217796 Neutralizing human anti-IGFR antibody |
| 05/15/2007 | US7217734 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/15/2007 | US7217732 Cannabinoid receptor agonists |
| 05/15/2007 | US7217729 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies |
| 05/15/2007 | US7217724 2-[(2-hydroxy-2-pyridinylethyl)amino]ethyl-substituted indoles, e.g., N,N-Diethyl-2-{3-[(2R)-2-((2R)-2-hydroxy-2-pyridin-3-ylethylamino)-propyl]-1H-indol-7-yloxy}acetamide; beta 3-adrenoceptor stimulants, used for treating obesity, hyperglycemia, frequent urination, and urinary incontinence |
| 05/15/2007 | US7217706 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
| 05/15/2007 | US7217701 Intracellular calcium concentration increase inhibitors |
| 05/15/2007 | CA2392973C Benzoimidazole derivatives useful as antiproliferative agents |
| 05/15/2007 | CA2366829C Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 05/15/2007 | CA2366186C Retinoid antagonists and use thereof |
| 05/10/2007 | WO2007052794A1 o-SUBSTITUTED ANILINE DERIVATIVE AND ANTIOXIDANT DRUG |
| 05/10/2007 | WO2007051463A2 Use of an activated zeolite as a pharmaceutical agent for reducing poisonous substances |
| 05/10/2007 | WO2007020286A3 Method of using potassium channel inhibiting compounds |
| 05/10/2007 | WO2007007282A3 Azabicyclo derivatives as muscarinic receptor antagonists |
| 05/10/2007 | WO2007007281A3 Muscarinic receptor antagonists |
| 05/10/2007 | US20070106076 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino [1,2-a] indoles |
| 05/10/2007 | US20070105958 Compounds for the treatment of metabolic disorders |
| 05/10/2007 | US20070105949 Intermediates for the preparation of lipoxin A4 analogs |
| 05/10/2007 | US20070105933 Amino alcohol compounds |
| 05/10/2007 | US20070105908 Thiazolimine compound and oxazolimine compound |
| 05/10/2007 | US20070105901 Novel piperidine derivative |
| 05/10/2007 | US20070105899 Benzene compounds |
| 05/10/2007 | US20070105897 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 05/10/2007 | US20070105894 Combination of at least two compounds selected from an AT1-receptorantagonist or an ACE inhibitor or a HMG-Co-A reductase inhibitor |
| 05/10/2007 | US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors |